Similar articles for PMID: 18350592

Year	Number of Results
1986	1
1998	1
2001	1
2002	3
2003	1
2004	5
2005	5
2006	5
2008	4
2009	4
2010	8
2011	2
2012	6
2013	6
2014	4
2015	4
2016	5
2017	8
2018	6
2019	6
2020	4
2024	0

1

Novel therapeutic approaches for hepatocellulcar carcinoma: fact and fiction.

Zhang YY, Xia HH. Zhang YY, et al. World J Gastroenterol. 2008 Mar 21;14(11):1641-2. doi: 10.3748/wjg.14.1641. World J Gastroenterol. 2008. PMID: 18350592 Free PMC article.

2

Molecular pathogenesis of hepatocellular carcinoma.

McKillop IH, Moran DM, Jin X, Koniaris LG. McKillop IH, et al. J Surg Res. 2006 Nov;136(1):125-35. doi: 10.1016/j.jss.2006.04.013. Epub 2006 Oct 3. J Surg Res. 2006. PMID: 17023002 Review.

3

[Pathogenesis and selection of treatment modalities for hepatocellular carcinoma].

Okamura J, Monden M, Sakon M, Mori T, Kuroda C, Sakurai M. Okamura J, et al. Gan To Kagaku Ryoho. 1986 Feb;13(2):203-9. Gan To Kagaku Ryoho. 1986. PMID: 3004362 Japanese.

4

Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma.

Klungboonkrong V, Das D, McLennan G. Klungboonkrong V, et al. J Vasc Interv Radiol. 2017 Jul;28(7):949-955. doi: 10.1016/j.jvir.2017.03.002. Epub 2017 Apr 14. J Vasc Interv Radiol. 2017. PMID: 28416267 Review.

5

[Hepatocellular carcinoma].

Czauderna C, Marquardt JU, Galle PR, Wörns MA. Czauderna C, et al. Internist (Berl). 2017 May;58(5):469-479. doi: 10.1007/s00108-017-0226-z. Internist (Berl). 2017. PMID: 28386626 Free article. Review. German.

6

Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.

Abdel-Rahman O. Abdel-Rahman O. J Egypt Natl Canc Inst. 2013 Dec;25(4):165-71. doi: 10.1016/j.jnci.2013.08.002. Epub 2013 Sep 21. J Egypt Natl Canc Inst. 2013. PMID: 24207088 Free article. Review.

7

Hepatocellular carcinoma: systemic therapies and future perspectives.

Mikhail S, Cosgrove D, Zeidan A. Mikhail S, et al. Expert Rev Anticancer Ther. 2014 Oct;14(10):1205-18. doi: 10.1586/14737140.2014.949246. Epub 2014 Sep 9. Expert Rev Anticancer Ther. 2014. PMID: 25199765 Review.

8

Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients.

D'Aleo F, Ceccarelli M, Venanzi Rullo E, Facciolà A, Di Rosa M, Pinzone MR, Condorelli F, Visalli G, Picerno I, Berretta M, Pellicanò GF, Nunnari G. D'Aleo F, et al. Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5859-5867. doi: 10.26355/eurrev_201712_14035. Eur Rev Med Pharmacol Sci. 2017. PMID: 29272025 Free article. Review.

9

Pathogenesis of hepatocellular carcinoma and molecular therapies.

Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM. Mínguez B, et al. Curr Opin Gastroenterol. 2009 May;25(3):186-94. doi: 10.1097/MOG.0b013e32832962a1. Curr Opin Gastroenterol. 2009. PMID: 19387255 Review.

10

The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.

Marotta F, Vangieri B, Cecere A, Gattoni A. Marotta F, et al. Clin Ter. 2004 May;155(5):187-99. Clin Ter. 2004. PMID: 15344567 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year